Expression and clinical significance of microRNA-29b in the epithelian ovarian cancer

Sun Shuangshuang,Wang Liming,Zhang Haifeng

DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2012.04.010

2012-01-01

Abstract:Objective:To detect the miR-29b expression in the epithelial ovarian cancer,and analyze the correlation of its expression with clinicopathological features.Methods:real-time PCR was employed to quantify the miR-29b expression in 90 ovarian specimens(including 15 normal,15 benign and 60 malignant).The relevance between the miR-29b expression and the pathoclinical characteristics was assessed with statistics analysis.Results:(1)The expression of miR-29b was significantly down-regulated in patients with ovarian carcinoma compared to those with ovarian benign tumors and normal controls.(2)miR-29b expression was significantly associated with FIGO stage,lymph node metastasis and presence of hydroperitoneum(P<0.05),but not with ages,grades of cytology,differentiation,histological types,and sizes of residual tumors in epithelial ovarian cancer(P>0.05).In stage Ⅲ~Ⅳ and in the group with lymph node metastasis miR-29b were significantly down-regulated compared to those in stageⅠ~Ⅱ and in the group without lymph node metastasis respectively(P<0.05).Hydroperitoneum was associated with low expression of miR-29b(P<0.05).(3)Kaplan-Meier method showed that patients survived shorter when ovarian cancer tissues showed lower expression of miR-29b(P<0.05);COX proportional risk model analysis indicated that lower expression of miR-29b was independently related to survival time,and the risk of mortality with lower expression of miR-29b was 3.996 times as large as that with high expression.Conclusions:miR-29b may participate the origination and progression of epithelial ovarian cancer as a tumor-suppressor.It may represent potential indicator in the auxiliary diagnosis and prognosis of epithelial ovarian cancer.